Can a Pap Smear Detect Cervical Cancer, or Only Precancer?
It can detect both — but it is designed for one of them. A Pap smear looks for abnormal cells shed from the surface of the cervix, and its real purpose is to find precancerous change years before any cancer exists. When an invasive cancer is present, the smear will usually come back abnormal and trigger the tests that identify it, so in that sense it does detect cancer. What it never does is diagnose one: a diagnosis of cervical cancer is made by a biopsy, not by a smear. This page explains what the report categories mean, why a smear can occasionally miss a cancer, and when a normal result should not close the question. CION runs cervical screening across 7 NABH-accredited Hyderabad locations.
- A screening test, not a diagnostic one — it identifies who needs a closer look, not what they have
- Best at finding precancer — the stage that is fully treatable in a single outpatient procedure
- A single smear can miss things — which is why programmes repeat it, and why symptoms override a normal result
- Pap and HPV test in one visit — with a woman doctor available on request at every CION location
on Panel
Survival Rate*
Treated
(800+ reviews)
The Direct Answer: It Detects, It Does Not Diagnose
A Pap smear collects cells from the surface of the cervix and a pathologist examines them for abnormal change. Three things follow from that, and together they answer the question completely.
- Yes, it can pick up an existing cancer. Invasive tumours shed abnormal cells, and a report can come back showing high-grade change or, occasionally, cells suspicious for invasive carcinoma. That result sends you straight for colposcopy.
- No, it cannot confirm one. Cytology looks at loose cells; it cannot show whether abnormal cells have broken through into the tissue beneath, which is the actual definition of invasion. Only a biopsy answers that.
- Its real job is the stage before cancer. A smear is at its most valuable when it finds CIN 2 or CIN 3 in a woman who feels perfectly well — precancer, years ahead of any tumour, treatable in one outpatient visit.
Put simply, a Pap smear is a sorting test. It divides women into those who can safely wait for the next round and those who need a closer look now. If you want the practical detail of the appointment itself — what is done, whether it hurts, how long results take — read our guide to what a Pap smear involves and what to expect.
What the Categories on Your Report Actually Mean
Most Indian laboratories report cervical cytology using the Bethesda system. These are the terms you are most likely to see, in plain language.
NILM
“Negative for intraepithelial lesion or malignancy”. No abnormal cells were seen in this sample. This is the result the great majority of women receive, and it means you return at your next scheduled interval.
ASC-US
Cells look slightly unusual, but not clearly abnormal. This is the mildest abnormal category and very often means nothing at all. It is usually sorted by adding an HPV test: negative, and you go back to routine screening; positive, and you are referred for colposcopy.
LSIL
Low-grade change consistent with an active HPV infection and CIN 1. A large proportion regresses on its own, particularly in younger women, so this is frequently monitored rather than treated. It is not cancer and does not become cancer quickly.
HSIL
High-grade change, corresponding to CIN 2 or CIN 3. This is genuine precancer and is the finding screening exists to catch. It is referred for colposcopy and usually treated by removing the affected zone in one outpatient procedure. It is still not cancer.
ASC-H
Atypical cells where a high-grade lesion cannot be ruled out. The sample was not clear enough to grade confidently, so it is treated as high-grade until colposcopy proves otherwise. Referral is prompt rather than watchful.
AGC
Atypical glandular cells, which come from the canal rather than the outer surface. This category matters because it can point to adenocarcinoma or to disease in the uterine lining, and it always warrants thorough assessment even though the finding itself is uncommon.
Suspicious for Invasive Carcinoma
The pathologist has seen cells that suggest invasive cancer rather than precancer. This is uncommon on a screening smear, and it is the one result that is acted on immediately — colposcopy and biopsy, then staging if the biopsy confirms it.
Unsatisfactory / Inadequate
Too few cells, or blood, inflammation or lubricant obscuring them. It is not a bad result and not a good one — it is no result. The test simply needs repeating, usually after a few weeks or after treating an infection.
Whether a Pap smear, an HPV test, or both together is the right test for you is covered in detail in HPV DNA test vs Pap smear — which and when.
Why a Pap Smear Can Miss a Cancer
No screening test finds everything on every occasion, and cytology is no exception. Being honest about how a smear fails is what makes the advice that follows it useful.
1. Sampling — the brush has to reach the abnormal cells
A smear samples the transformation zone on the outer cervix. A lesion sited high inside the endocervical canal may shed few cells into that sample. The technique of the person taking it, and whether the transformation zone was adequately sampled, genuinely affect the result.
2. Adenocarcinoma is harder for cytology to catch
The glandular subtype arises higher in the canal and does not produce the classic squamous abnormalities cytology is best at recognising. This is one reason a normal smear does not settle the matter in a woman with persistent symptoms, and one reason HPV-based screening has gained ground.
3. The slide can be obscured
Heavy bleeding, marked inflammation, infection or lubricant can hide the cells that matter. Well-run laboratories call this out as an unsatisfactory sample rather than report it as normal, which is why an unsatisfactory result should always be repeated rather than quietly filed.
4. Interpretation has limits
Cytology is a judgement made by a human being looking at cells under a microscope, and borderline appearances are genuinely difficult. Laboratory accreditation, adequate volumes and internal quality control reduce this — they do not abolish it.
5. One test is not the programme
Screening works cumulatively. What protects a woman is being tested repeatedly at the recommended interval over decades, so that something missed on one occasion is caught on the next. Judging cytology by the performance of a single smear misunderstands how it is meant to be used.
The rule that follows from all five: a normal Pap smear reassures a woman with no symptoms. It does not overrule a symptom. Bleeding after sex, bleeding after the menopause, bleeding between periods or a persistent unusual discharge needs the cervix examined, whatever the last smear said and however recently it was done. Read the wider context on our cervical cancer overview.
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Mohammed Imran
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
An Abnormal Smear Is a Question, Not a Verdict
Colposcopy is available in-house at CION, so the answer comes without a second referral and a second wait. Same-week appointments across Hyderabad, woman doctor on request.
What Happens Between an Abnormal Smear and an Actual Diagnosis
This is the part most women have never had explained, and it is where the difference between screening and diagnosis becomes obvious.
Step 1 — Triage: does this result need colposcopy now?
Not every abnormal smear leads straight to the next test. Borderline changes are often triaged with an HPV test, because a negative HPV result in that setting is strongly reassuring. High-grade findings, glandular abnormalities and anything suspicious for invasion skip triage and go directly to colposcopy.
Step 2 — Colposcopy: looking at what the cells came from
The cervix is viewed under magnification after dilute acetic acid and iodine are applied, which make abnormal areas stand out. It is an outpatient examination that feels much like having a smear taken, with the speculum in place a little longer. For the first time in the process, someone is looking directly at the tissue rather than at cells that fell off it.
Step 3 — Biopsy: the step that actually decides
A small sample is taken from any abnormal area. The pathologist can now see the architecture of the tissue and answer the question cytology could not: have abnormal cells stayed within the surface layer, or have they broken through it? That distinction is the boundary between precancer and cancer, and it is the reason no responsible clinician calls a smear a diagnosis.
Step 4 — If it is precancer, treatment usually ends the story
High-grade precancer is normally treated by removing the affected zone in a single outpatient procedure, followed by tests to confirm the change has gone. The uterus is not removed and fertility is not usually affected.
Step 5 — If it is cancer, staging and tumour board come next
Confirmed invasive cancer proceeds to examination, pelvic MRI and, where indicated, PET-CT, then to CION's multidisciplinary tumour board before any plan is proposed, in line with NCCN, FIGO and ESMO guidance. What follows is set out on our cervical cancer treatment in Hyderabad page.
Your Result and What Usually Happens Next
A guide to the usual pathway. Local protocols and your own history can change it, so treat this as orientation and confirm the plan with the clinician who has your report.
| What the report says | What it means | Usual next step |
|---|---|---|
| NILM (normal) | No abnormal cells seen in this sample | Return at your scheduled interval; act on symptoms if they appear |
| ASC-US | Borderline changes, frequently insignificant | HPV test to triage; colposcopy only if HPV-positive |
| LSIL | Low-grade change, often an active HPV infection | Colposcopy or a repeat test, depending on age and history |
| ASC-H | High-grade lesion cannot be excluded | Colposcopy, without waiting for a repeat smear |
| HSIL | High-grade precancer — CIN 2 or CIN 3 | Colposcopy and biopsy; treatment of the affected zone if confirmed |
| AGC / glandular abnormality | Atypical cells from the cervical canal or uterine lining | Colposcopy with endocervical assessment; further imaging if indicated |
| Suspicious for invasive carcinoma | Cells suggest invasion rather than precancer | Urgent colposcopy and biopsy, then staging if confirmed |
| Unsatisfactory / inadequate | No usable result — the slide could not be read | Repeat the test; treat any infection first if one is present |
Not one row on this table says “you have cancer”. A smear can raise the question — only a biopsy answers it.
When a Normal Pap Smear Should Not End the Conversation
Three situations come up repeatedly in clinic, and in each the temptation is to be reassured by a piece of paper rather than by an examination.
You have a symptom that has not gone away
Bleeding after sex, any bleeding after the menopause, bleeding between periods, or a discharge that has changed and persisted — each of these is an indication for someone to look at your cervix. A smear taken six months ago cannot tell you what your cervix looks like today, and a smear taken today does not replace the act of looking. If a doctor declines to examine you on the strength of a normal smear, that is a reason to ask again.
Your result was unsatisfactory and never repeated
An inadequate sample is the easiest result in medicine to lose track of, because it does not sound alarming. It is not a normal result. If a report told you the sample was unsatisfactory and nobody arranged a repeat, arrange one yourself.
You were told “mild changes, come back later” and never went
Low-grade change genuinely does regress in a large share of women, which is why watchful follow-up is a legitimate plan. It only works if the follow-up happens. Where the interval has slipped by years rather than months, the sensible move is to be re-tested now rather than to resume the original schedule as though nothing had lapsed.
Why the timing of all this matters
Stage at diagnosis is the strongest single influence on outcome in cervical cancer. CION reports a 1-year survival of 83.3% for cervical cancer against a national figure of 67.3%, and the largest contributors to a gap like that are how early women present and how consistently plans follow tumour board review. No hospital can promise an outcome. What you can influence is whether an unanswered question is left open for another year.
Why Women in Hyderabad Come to CION for Screening
A test is only as useful as what happens after it. The point of screening here is that the next step is already in the building.
Pap and HPV test from one sample
On-site colposcopy and biopsy
Woman doctor available on request
Your report explained in plain language
45-minute detailed consultation
Tumour board for every cancer diagnosis
7 NABH-accredited Hyderabad locations
Transparent, itemised costs
4.8 / 5 Google rating
Get the Test, and Get the Result Explained
Whether you are booking a first smear or trying to make sense of a report you already have, one appointment is enough to know where you stand.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Pap Smears and Cancer Detection — Frequently Asked Questions
Can a Pap smear miss cervical cancer?
Yes, occasionally, and it is important to say so plainly. The usual reasons are sampling — a lesion sited high in the endocervical canal may shed few cells into the sample — and the glandular subtype, adenocarcinoma, which does not produce the classic squamous abnormalities cytology recognises best. Blood, inflammation or lubricant can also obscure the slide, and borderline appearances are genuinely difficult to interpret. This is why screening is designed as a repeated programme rather than a one-off test, why an HPV test alongside cytology adds sensitivity, and above all why a normal smear never overrules a persistent symptom. If you are bleeding after sex or after the menopause, ask for an examination regardless of your last result.
Does an abnormal Pap smear mean I have cancer?
Almost never. The overwhelming majority of abnormal smears reflect either an active HPV infection that will clear on its own or precancerous cell change that can be treated completely in one outpatient procedure. Borderline categories such as ASC-US frequently turn out to mean nothing at all once an HPV test is added. Even a high-grade result, which sounds the most frightening, describes CIN 2 or CIN 3 — precancer, not cancer. A smear can only ever raise a question, because cytology examines loose cells and cannot show whether abnormal cells have invaded the tissue beneath. That distinction is made by a biopsy taken at colposcopy.
Is a Pap smear or an HPV test better at finding cervical cancer?
They answer different questions. An HPV test looks for the virus that causes almost all cervical cancer and is more sensitive, so a negative HPV result is more reassuring than a negative smear and allows longer intervals between tests. A Pap smear looks at the cells themselves and is better at showing whether damage has already occurred, which makes it useful for deciding which HPV-positive women need colposcopy immediately. WHO now recommends HPV testing as the preferred primary screening test, with cytology used to triage. In practice both can be run from a single sample taken in one appointment, which is how CION does it.
My Pap smear was normal but I am still bleeding after sex. What should I do?
Ask for an examination of your cervix, and do not let the normal smear end the conversation. Bleeding after sex has many benign explanations — cervical ectropion, a polyp, infection, dryness — but it is also the most characteristic early symptom of cervical cancer, and a smear samples cells rather than looking at the cervix directly. A speculum examination takes about a minute and frequently identifies the cause on the spot. If anything looks abnormal, colposcopy follows. A symptom that persists deserves its own assessment on its own merit, whatever a screening test said and however recent it was.
What does an unsatisfactory or inadequate Pap smear report mean?
It means the laboratory could not read the sample, so there is no result at all — neither good nor bad. Usual causes are too few cells collected, or blood, marked inflammation, infection or lubricant obscuring the slide. It is not a sign that something was found. The correct response is simply to repeat the test, generally after a few weeks, and after treating an infection first if one is present. The risk with this result is administrative rather than medical: because it does not sound alarming, the repeat is often never arranged. If your report said unsatisfactory and nobody called you back, book the repeat yourself.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It explains how a screening test is used and cannot interpret your individual report. If you have an abnormal result, an unsatisfactory result, or symptoms of any kind, please see a doctor rather than relying on any website.